Detailed View
TMO - Thermo Fisher Scientific Inc
Latest filing: 2026-06-27 | Reporting: gaap
Market Cap
226,939,797,504
Adj EBIT (TTM)
8,465,000,000
Enterprise Value
265,431,797,504
Last Price
613.77
Earnings Yield
3.19%
Return on Capital
34.32%
Capital
24,667,000,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-27 | 10-Q | 2026 | 11,994,000,000 | 2,087,000,000 |
| 2026-03-28 | 10-Q | 2026 | 11,005,000,000 | 1,863,000,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 12,215,000,000 | 2,255,000,000 |
| 2025-09-27 | 10-Q | 2025 | 11,122,000,000 | 1,941,000,000 |
| 2025-06-28 | 10-Q | 2025 | 10,855,000,000 | 1,834,000,000 |
| 2025-03-29 | 10-Q | 2025 | 10,364,000,000 | 1,716,000,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 11,395,000,000 | 2,016,000,000 |
| 2024-09-28 | 10-Q | 2024 | 10,598,000,000 | 1,838,000,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.